Description
Latin name
LAVASEPT
Dosage form
Concentrate for solution for external use
Pharmacological action
LAVASEPT – antiseptic.
Polyhexanide has a wide spectrum of antimicrobial activity.
Active against:
Gram-positive and gram-negative bacteria (including Pseudomonas aeruginosa).
Mushrooms.
Polyethylene glycol (PEG) reduces surface tension, which enhances the action of polyhexanide.
In the presence of protein (0.2% albumin), the effect of the drug is only slightly attenuated, and when conducting quantitative tests, a good fungicidal and bactericidal effect is revealed.
The product does not contain irritating substances: halogen and mercury-containing antiseptics, iodine, heavy metals, polyvinylpyrrolidone and aldehydes.
Polyhexanide is chemically stable, non-volatile, odorless, soluble in water, ethanol, glycerin, propylene glycol and other solvents.
Polyhexanide has low toxicity, and the polyethylene glycol content in Lavasept concentrate is small in order to enhance the toxicity of polyhexanide.
Indications
² antiseptic treatment in the surgical treatment of infected wounds and superficial soft tissue injuries
² washing cavities through drainage tubes using active
drainage ² irrigating the surgical field during surgery during reconstructive surgery, immediately before bone and soft tissue srd transplantation irrigation of the surgical field during operations with an existing threat of
infection ² treatment of infected wounds during hip joint surgery (according to Schneider)
² antiseptic protection of open wounds
² treatment of burn surfaces
² antiseptic treatment during maxillofacial surgery
² treatment of surgical instruments, dressings and patient care items.
Contraindications
surgery on uninfected joints
surgery on the brain and spinal cord (neurosurgery)
surgery on the middle and inner ear
surgery on the eyes (ophthalmologic surgery) sensory sensitivity on-the-spot sensitivity
Use during pregnancy and lactation
There is currently insufficient data on the use of Lavasept concentrate during pregnancy and lactation.
It is not recommended to use the drug in the first trimester of pregnancy.
In later pregnancy and lactation, use is only possible if the intended benefit to the mother outweighs the potential risk to the fetus or child.
Composition
Polyhexanide
Excipients:
water d / i,
Macrogol 400 (PEG) 10 mg
Dosage and administration
Lavasept concentrate is used only externally. Before using Lavasept, the concentrate should be diluted to a concentration of 0.1% or 0.2%.
For washing and draining wounds, 0.1% Lavasepta concentrate solution should be used.
In case of infection of wounds with gram-negative flora, use a 0.2% solution of the drug.
Rules for the preparation of
solution To prepare a 0.1% or 0.2% Lavasept solution, 1 ml or 2 ml Lavasept concentrate should be added to 1000 ml of Ringer’s solution, respectively. When mixed with other solutions, cloudiness and precipitation should be avoided. The polyhexanide precipitated at low temperatures can be dissolved by heating the solution to 60 ° C.
Side effects
Allergic reactions: skin rash, urticaria.
Drug Interaction
No drug interaction is currently known.
Overdose
Overdose has not been reported.
Storage conditions
The drug should be stored at a temperature of 8 ° to 25 ° C. Do not freeze.
Shelf suitability
3 Year
Deystvuyuschee substances
Polyheksanyd
pharmacy leave terms for prescription
